WAM
RNTX

Warberg Asset Management’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History

Warberg Asset Management’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,000
Closed -$35.4K – 226
2024
Q3 		$35.4K Sell
10,000
-21,354
-68% -$75.6K 0.01% 110
2024
Q2 		$86.2K Buy
+31,354
New +$86.2K 0.01% 108